Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
JAMA Ophthalmology|February 2, 2023
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular EdemaDavid W Hutton, Adam R Glassman, Danni Liu, et al.
Annals of Internal Medicine|December 17, 2009
Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemicNayer Khazeni, David W Hutton, Alan M Garber, et al.
Vaccine|April 24, 2019
Are community health workers cost-effective for childhood vaccination in India?Deepti Bettampadi, Matthew L Boulton, Laura E Power, et al.
Annals of Internal Medicine|October 3, 2007
Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis BDavid W Hutton, Daniel Tan, Samuel K So, et al.
Gastroenterology|October 28, 2017
Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care ProvidersThilo Rattay, Ian P Dumont, Hauke S Heinzow, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 3, 2002
A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcersAristidis Veves, Peter Sheehan, Hau T Pham
Current Diabetes Reports|January 25, 2005
Peripheral arterial disease: clinical assessment and indications for revascularization in the patient with diabetesBart E Muhs, Paul Gagne, Peter Sheehan
The American Journal of Gastroenterology|June 13, 2020
Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and HarmsNeehar D Parikh, Amit G Singal, David W Hutton, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 1, 2011
Does use of the adjuvant! model influence use of adjuvant therapy through better risk communication?Jeffrey K Belkora, David W Hutton, Dan H Moore, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 16, 2009
Are patients getting the "gist" in risk communication? Patient understanding of prognosis in breast cancer treatmentDavid W Hutton, Jeffrey K Belkora, Ross D Shachter, et al.
Pageof 13